These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6492243)

  • 1. Effects of disopyramide on the electrocardiogram and ventricular function in the unanesthetized dog.
    Crosby HH; Hamlin RL; Strauch SM
    J Vet Pharmacol Ther; 1984 Sep; 7(3):167-75. PubMed ID: 6492243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective effects of disopyramide enantiomers in humans.
    Lima JJ; Boudoulas H
    J Cardiovasc Pharmacol; 1987 May; 9(5):594-600. PubMed ID: 2439842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A; Motomura S; Tamura K; Hashimoto K
    Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.
    Pollick C; Giacomini KM; Blaschke TF; Nelson WL; Turner-Tamiyasu K; Briskin V; Popp RL
    Circulation; 1982 Aug; 66(2):447-53. PubMed ID: 7094252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial and ventricular mechanics as influenced by disopyramide.
    Vogt M; Mohrmann J; Ott B; Jacob R
    Arzneimittelforschung; 1986 Jul; 36(7):1049-53. PubMed ID: 3768071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
    Hidaka T; Inoue T; Komoriya K; Hayashi Y; Inomata N
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):295-308. PubMed ID: 10872181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the negative inotropic effect of disopyramide.
    Kenedi PP
    J Int Med Res; 1988; 16(4):257-63. PubMed ID: 3169371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1979 Jun; 66(2):241-50. PubMed ID: 465877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography, a non-invasive method for the investigation of heart morphology and function in laboratory dogs: 2. Effects of minoxidil and quinidine on the left ventricle function.
    Hanton G; Lodola A
    Lab Anim; 1998 Apr; 32(2):183-90. PubMed ID: 9587901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of conventional oral dose of disopyramide on left atrial and ventricular functions.
    Arakawa M; Miwa H; Noda T; Kagawa K; Nishigaki K; Ito Y; Kawada T; Hirakawa S
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):253-9. PubMed ID: 8314654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiology of the enantiomers of disopyramide in dogs.
    Giacomini JC; Giacomini KM; Nelson WL; Harrison DC; Blaschke TF
    J Cardiovasc Pharmacol; 1985; 7(5):884-90. PubMed ID: 2413296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of disopyramide on postischemic and normal myocardium].
    Hoffmeister HM; Hörmann HP; Beyer M; Seipel L
    Klin Wochenschr; 1990 Dec; 68(23):1178-82. PubMed ID: 2280581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
    Campbell JK; Marshall RJ; Winslow E
    Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.